semaglutide for fertility GLP-1 Receptor Agonists, Restoration, and Reproductive Safety in Women of Reproductive Age: A Narrative Review Ozempic and Fertility: Understanding the

These effects make GLP-1 weight loss therapies a potential option for individuals struggling with obesity or weight-related conditions

Study period 1/1/2021 to 10/1/2024 with follow-up possible through 7/1/2025 Study population: inclusion Patients with: PCOS (encounter or billing diagnosis with ICD-10-CM code E28.2) before exposure or within two years of drug trial start Evaluated sex of female or ambiguous Aged 18 to 50 at drug trial start No overlap in metformin and GLP-1 use At least one measurement within one year prior to trial start At least one measurement 9 to 15 months after trial start At least 70% of days covered by their exposure medication dispense Study population: exclusion Patients with: Evidence of pregnancy during baseline or outcome measurements Definitive pregnancy start date: Between 12 months before the first reading through the follow-up reading Definitive pregnancy end date, delivery, or if its ambiguous what point in the pregnancy the patient would be at (e.g

In normoglycemic and hyperglycemic conditions, the administration of GIP in healthy individuals suppresses glucagon secretion

Brands that dial down the extremes [in taste] may be better placed to protect the appeal amongst lower appetite consumers without alienating the mainstream, says Andy Wardlaw, chief ideas officer at MMR Research

Use Proper Injection Technique for Comfort Getting the injection technique right not only helps with medication absorption but also makes the process more comfortable

A yeast infection lasts 3-7 days with treatment